A new 'on' signal for inflammation

May 14, 2013, University College Dublin

(Medical Xpress)—Inflammation is an important response in the body - it helps you to kill off invaders such bacteria that could cause a harmful infection. But if it's chronic or uncontrolled, inflammation can also cause trouble in conditions including rheumatoid arthritis, inflammatory bowel disease and a potentially fatal immune reaction to infection called sepsis.

A new study involving UCD researchers has discovered a signal that appears to trigger inflammation when the threat of a looms, and the experiments have also been able to block the signal in lab models, pointing to possible new approaches to treating .

The study, which was published in Nature and led by Trinity College Dublin, found that in the presence of a potential bacterial threat, called change how they burn energy. This switch in burning eventually leads to the build-up of a molecule called succinate in the cells, and this in turn triggers a chain of biochemical events that encourage inflammation.

One link in that chain is a molecule called hypoxia-induced factor 1a (HIF-1a). HIF-1a is best known for its role in helping you adapt to conditions of low oxygen, such as when you climb a high mountain and the ambient dip, explains Conway Fellow, Professor Cormac Taylor from UCD School of Medicine & Medical Science.

"When you go to high altitude, this factor gets expressed in cells and that helps to increase the number of red blood cells in your blood, so you can adapt to the lower oxygen," he explains.

But that's not the only place that HIF-1a has a job to do. "At time of stress including inflammation you also experience an activation of this HIF pathway," says Prof Taylor. "And previous work in our lab has looked at this in models of ."

In the new study, which was led by Prof Luke O'Neill at Trinity, Prof Taylor and Research Fellow Dr Eoin Cummins from UCD helped to work out that in macrophages sensing a bacterial threat, the build-up of succinate seems to 'tell' HIF-1a to switch on an inflammatory gene.

"In this case, HIF drives a gene called interleukin-1, which is a potent pro-inflammatory gene," explains Prof Taylor. "And that will contribute to the inflammatory process."

The new study makes an important link between energy burning processes in the immune system and an 'on' signal for inflammation, according to Prof Taylor. The research also showed that a drug usually used for epilepsy was able to tone down this succinate/HIf-1a pathway in a lab model of sepsis, and this could point to new approaches to intervening when inflammation is running out of control, he adds.

"It's a big emerging area, the links between metabolism, or energy burning, and inflammation in disease," says Prof Taylor. "And in the future we could be targeting these metabolic pathways for beneficial purposes in inflammation."

Explore further: Illuminating cross talk between signalling factors

Related Stories

Illuminating cross talk between signalling factors

November 22, 2011
(Medical Xpress) -- Hypoxia and inflammation are environmental features occuring simultaneously in a variety of diseases such as growing tumours and critically inflamed tissues. UCD scientists investigating the relative contributions ...

Lack of oxygen in cancer cells leads to growth and metastasis

September 13, 2012
(Medical Xpress)—It seems as if a tumor deprived of oxygen would shrink. However, numerous studies have shown that tumor hypoxia, in which portions of the tumor have significantly low oxygen concentrations, is in fact linked ...

Researchers reveal that immune system like a turbo-charged hybrid car

April 4, 2013
(Medical Xpress)—Trinity College Dublin scientists have made a significant breakthrough in understanding the immune system that could lead to new treatments for diseases such as sepsis and Type 2 diabetes. A team led by ...

Researchers link stress and pancreatic cancer in new paper

February 15, 2013
Pancreatic cancer is a deadly disease with increased incidences in the recent years. According to NDSU researchers, epidemiological data show chronic stress in a negative social and psychological state such as depression ...

Key pathway to stop dangerous, out-of-control inflammation discovered

April 9, 2013
A potential new strategy to developing new drugs to control inflammation without serious side effects has been found by Georgia State University researchers and international colleagues.

Recommended for you

Chronic inflammation causes loss of muscle mass during aging

January 12, 2018
People start losing muscle mass at the age of 40—about some 10 percent of the total muscle mass for each 10-year period, which may lead to fall-related injuries, slowing metabolism and reduced quality of life. Today, very ...

Breathing exercises help asthma patients with quality of life

December 13, 2017
A study led by the University of Southampton has found that people who continue to get problems from their asthma, despite receiving standard treatment, experience an improved quality of life when they are taught breathing ...

Study highlights the need for research into prevention of inflammatory bowel disease

December 7, 2017
Countries in Africa, Asia, the Middle East and South America have seen a rise in incidence of inflammatory bowel disease as they have become increasingly industrialised and westernised, a new study has found.

Air pollution can increase asthma risk in adults, even at low levels

November 24, 2017
Living close to a busy road can be bad for your respiratory health if you are middle aged, new Australian research has found.

Evidence found of oral bacteria contributing to bowel disorders

October 20, 2017
(Medical Xpress)—An international team of researchers has found evidence that suggests certain types of oral bacteria may cause or exacerbate bowel disorders. In their paper published in the journal Science, the group describes ...

New compound discovered in fight against inflammatory disease

September 22, 2017
A 10-year study by University of Manchester scientists for a new chemical compound that is able to block a key component in inflammatory illness has ended in success.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.